Virtus LifeSci Biotech Products ETF(BBP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BBP Virtus LifeSci Biotech Products ETF

盘后交易 10-13 18:47:55 EDT

100.71

-2.92

-2.82%

盘后100.71

+0.000.00%

16:10 EDT

最高103.68	最低100.71	成交量1.23万
今开103.68	昨收103.63	日振幅2.87%
总市值1.26亿	流通市值1.26亿	总股本125.00万
成交额125.26万	换手率0.99%	流通股本125.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":100.7072,"timestamp":1791921600000,"preClose":103.6299,"halted":0,"volume":12317,"hourTrading":{"tag":"盘后","latestPrice":100.7072,"preClose":100.7072,"latestTime":"16:10 EDT","volume":6,"amount":604.2432,"timestamp":1791922204896,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02820325022025502,"floatShares":1250004,"shares":1250004,"eps":0,"marketStatus":"盘后交易","change":-2.9227,"latestTime":"10-13 18:47:55 EDT","open":103.68,"high":103.68,"low":100.705,"amount":1252625,"amplitude":0.028708,"askPrice":136.8,"askSize":100,"bidPrice":87.8,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791936000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":103.6299,"sharesOutstanding":600004,"nav":104.84,"aum":131050460.64,"bidAskSpread":0.002428,"preHourTrading":{"tag":"盘前","latestPrice":103.6299,"preClose":103.6299,"latestTime":"07:01 EDT","volume":1,"amount":103.6299,"timestamp":1791889277032,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":100.7072,"preClose":100.7072,"latestTime":"16:10 EDT","volume":6,"amount":604.2432,"timestamp":1791922204896,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.187181,"impliedVol":0.2467,"impliedVolPercentile":0.6972},"requestUrl":"/m/hq/s/BBP/wiki","defaultTab":"wiki","newsList":[{"id":"2674342870","title":"纳微科技与智翔金泰签署战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2674342870","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674342870?lang=zh_cn&edition=full","pubTime":"2026-10-12 20:32","pubTimestamp":1791808379,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MRNX","MRNY","IBBQ","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674865591","title":"美股异动 | 美国临床阶段生物制药公司Retension Pharmaceuticals(RTSN.US)登陆美股市场 开盘后股价跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674865591","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674865591?lang=zh_cn&edition=full","pubTime":"2026-10-10 00:21","pubTimestamp":1791562908,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，Retension Pharmaceuticals(RTSN.US)登陆美股市场，截至发稿，该股跌超10%，报10.77美元。IPO价格为12美元。Retension Pharmaceuticals是一家美国临床阶段生物制药公司，专注于开发治疗高血压及其他心血管疾病的创新药物。公司的核心在研药物RTN-001是一款新一代磷酸二酯酶5(PDE5)抑制剂，主要针对血压未得到有效控制及难治性高血压患者，目前正开展IIb期临床试验。该药物通过增强血管中的一氧化氮信号传导，帮助血管舒张、降低血压，其全球独家开发许可来自法国制药巨头赛诺菲安万特(SNY.US)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505512.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MRNX","IBBQ","BK1610","RTSN","03069","MRNY","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673501811","title":"科创板集成电路、创新药研发成果进入实质兑现期","url":"https://stock-news.laohu8.com/highlight/detail?id=2673501811","media":"中国经营报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673501811?lang=zh_cn&edition=full","pubTime":"2026-10-07 19:56","pubTimestamp":1791374163,"startTime":"0","endTime":"0","summary":"近期，科创板公司研发频传利好消息，从创新药的首例入组和新适应证获批，到集成电路的存储平台量产与核心芯片交付，越来越多成果转化为实实在在的创新产出，科创板硬科技企业正从“持续投入”走向“成果兑现”。集成电路板块多点突破，存储、端侧AI、模拟与车规芯片均有实质进展落地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610073888922323.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610073888922323.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PBE","IBB","WRND","KSTR","LFSC","159546","SBIO","BBP","XLVI","GSKH","GDOC","BK4585","BK4588","APXH","BIOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672268507","title":"生物制药公司Agenus报告称，其BOT+BAL联合疗法在复发性卵巢癌患者中取得了48% 的估计三年生存率。","url":"https://stock-news.laohu8.com/highlight/detail?id=2672268507","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672268507?lang=zh_cn&edition=full","pubTime":"2026-10-03 23:04","pubTimestamp":1791039869,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1610","IBBQ","MRNY","MRNX","03069","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672753398","title":"三星生物制药与梯瓦制药扩大战略合作，推进至多六款候选生物类似药研发.","url":"https://stock-news.laohu8.com/highlight/detail?id=2672753398","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672753398?lang=zh_cn&edition=full","pubTime":"2026-10-01 16:30","pubTimestamp":1790843422,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4596","LU2322448791.USD","LU2324357040.USD","BK4557","BBP","BK4566","LU1992135472.HKD","LU1983299246.USD","TEVA","IBB","BK4585","XPH","LU2473716301.USD","BK4584","LU2272731600.USD","BK4588","BK4559","LU2322448957.HKD","BK4007","MRNX","LU2272731782.SGD","EMXC","IBBQ","LU2272731865.HKD","MRNY","PPH","IE00B5TLWC47.USD","LU1992135399.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671564271","title":"科创板收盘播报：科创综指跌1.81% 生物制药股涨幅靠前","url":"https://stock-news.laohu8.com/highlight/detail?id=2671564271","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671564271?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:34","pubTimestamp":1790753669,"startTime":"0","endTime":"0","summary":"新华财经北京9月30日电（罗浩）科创50指数和科创综指30日早间分别以0.46%和0.56%的涨幅高开。两股指早盘期间整体呈震荡下行态势，午后窄幅整理，收盘时均大幅下跌。截至收盘，科创50指数报1530.01点，跌幅2.51%，成分股总成交额约719亿元，成交额较上一交易日小幅放量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11134,202609303887685155.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11134,202609303887685155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["MRNY","000680.SH","BK1610","KSTR","MRNX","BBP","IBBQ","03069"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671949322","title":"纳微半导体美股盘前涨近13%，获得美国陆军拨款开发下一代10kV碳化硅功率半导体；生物制药公司SMMT大涨超23%，阿斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2671949322","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671949322?lang=zh_cn&edition=full","pubTime":"2026-09-29 16:03","pubTimestamp":1790669005,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","BK4139","STHH","MRNY","LU2488822045.USD","MRNX","BBP","SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671626576","title":"生物制药公司 CSL 表示，它正在与亚马逊网络服务合作，以推进生物制药研发，利用人工智能和云计算技术支持其研究和临床开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2671626576","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671626576?lang=zh_cn&edition=full","pubTime":"2026-09-29 07:58","pubTimestamp":1790639916,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FDIF","NEWZ","MQQQ","ARTY","GOGL","IBBQ","KOMP","CWC","OGIG","AQGX","AMZZ","SKYU","GOOL","MVPS","FBT","MSFC","FCLD","MRNY","AMZN","PBOT","CPNQ","GK","FWD","CLDL","QID","NBDS","AGIX","AIFD","QTOC","CHAT","BBP","WPAI","AIBU","QSWN","DQJN","TARK","CLDS","LRGE","VUSE","AIO","MFIG","QQA","LCLG","XT","TECY","SKYY","AIQU","ANEW","CLOU","BERZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669484013","title":"佳兆业健康(00876)：中文股份简称将更改为“青海生物制药”","url":"https://stock-news.laohu8.com/highlight/detail?id=2669484013","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669484013?lang=zh_cn&edition=full","pubTime":"2026-09-23 22:44","pubTimestamp":1790174658,"startTime":"0","endTime":"0","summary":"更改公司名称后，于香港联交所买卖股份之英文股份简称将由“KAISA HEALTH”更改为“QH BIO PHARMA”，而中文股份简称将由“佳兆业健康”更改为“青海生物制药”，自2026年9月28日上午九时正起生效。本公司于香港联交所之股份代号保持不变，仍为“876”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500165.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BBP","03069","BK1121","MRNX","MRNY","IBBQ","BK1222","00876","02954","BK1239","BK1154","BK1230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669114208","title":"安进股价盘前大涨逾4%，受第三期临床试验结果提振。","url":"https://stock-news.laohu8.com/highlight/detail?id=2669114208","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669114208?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:07","pubTimestamp":1790082475,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MRNY","XPH","XBIX","LU0109394709.USD","FTXH","AMGN","HELX","PBE","BBH","MRNX","PPH","CANC","BBP","AZNH","IBBQ","BK4585","RXL","LU2272731865.HKD","PBPH","SYNB","BME","GNOM","TBXU","IBRN","FBT","BIB","LU1992135472.HKD","LU2272731782.SGD","IEHS","LU2473716301.USD","LU2242646821.SGD","RSPH","WDNA","IE00B5TLWC47.USD","BIOY","BK4599","IE00B4R5TH58.HKD","LFSC","IEIH","PJP","IBB","LU0058720904.USD","MEDI","TMED","PSCH","LU0122379950.USD","SBIO","LU0320765992.SGD","IDNA","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669169682","title":"公告精选︱科达制造：拟投资约45亿元建设年产50万吨石墨负极材料一体化项目；百花医药：不涉及创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169682","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669169682?lang=zh_cn&edition=full","pubTime":"2026-09-21 21:52","pubTimestamp":1789998737,"startTime":"0","endTime":"0","summary":"逸豪新材：拟定增募资不超过18亿元用于增资收购铭丰电子不低于78%股权","market":"us","thumbnail":"https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6758003","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0102","BIOY","BK4585","BK0070","PBE","GSKH","IBB","BK0251","WRND","BK0155","GDOC","BBP","600499","BK0188","BK4588","600721","BK0216","XLVI","SETM","LFSC","APXH","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669695531","title":"Cue生物制药公司股价回吐盘前涨幅，最新跌幅为3.3%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2669695531","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669695531?lang=zh_cn&edition=full","pubTime":"2026-09-21 21:47","pubTimestamp":1789998468,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MRNX","BBP","IBBQ","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669137049","title":"创新药热度飙升，关注100%创新药研发标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2669137049","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669137049?lang=zh_cn&edition=full","pubTime":"2026-09-21 13:55","pubTimestamp":1789970100,"startTime":"0","endTime":"0","summary":"MACD金叉信号形成，这些股涨势不错！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-21/doc-inisqkzy8876594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","GDOC","BK4585","06978","WRND","LNGR","XLVI","IBBQ","BIOY","IBB","MEDX","159992","SBIO","BBP","GSKH","BK4588","APXH","PBE","LFSC","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668075449","title":"生物制药企业Electra美股上市：募资3.5亿美元 上半年亏4891万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2668075449","media":"雷递网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668075449?lang=zh_cn&edition=full","pubTime":"2026-09-20 10:32","pubTimestamp":1789871555,"startTime":"0","endTime":"0","summary":"生物制药企业Electra Therapeutics（股票代码：“ETRA”）日前在美国纳斯达克上市。","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260920/6392549715050864394546786.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260920/6392549715050864394546786.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n35194/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["MRNY","03069","IPOS","IBBQ","BBP","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666571008","title":"阿斯利康股价盘后跌超2%，因其三期临床试验结果令人失望。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666571008?lang=zh_cn&edition=full","pubTime":"2026-09-12 04:23","pubTimestamp":1789158183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IYH","HELX","IE00B5TLWC47.USD","CANC","XBIX","LU2272731600.USD","PBE","LU2272731782.SGD","RXL","LU2322448791.USD","AZNH","LU2322448957.HKD","RSPH","WDNA","PSCH","SBIO","IBRN","BIOY","IEIH","LU1992135399.USD","IDNA","IBB","FTXH","BBP","PPH","BIB","BK4585","BBH","LU1992135472.HKD","MEDI","PBPH","BK4588","GNOM","LU2473716301.USD","MRNY","TMED","BME","FBT","LU2272731865.HKD","LFSC","SYNB","XPH","IEHS","PJP","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666563124","title":"118款生物药专利悬崖将至，中国药企业迎战MNC最大专利悬崖","url":"https://stock-news.laohu8.com/highlight/detail?id=2666563124","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666563124?lang=zh_cn&edition=full","pubTime":"2026-09-10 15:26","pubTimestamp":1789025185,"startTime":"0","endTime":"0","summary":"BCG合伙人杜菁博士指出，未来几年全球MNC将迎来史上最大专利悬崖，有118种生物制剂将会失去相应的专利保护，涉及2340亿美元市场。然而，目前这118款即将到期分子中，只有极少数在火热开发，大量缺口有待生物类似药填补。目前来说，创新药出海还没办法完成这个闭环，但生物类似药作为先头部队做出海试验，企业风险和获益会更高。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789025064363150858","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["FHLC","159839","BBP","MEDI","GSKH","JDOC","IYH","PBPH","APXH","PJP","RSPH","IHE","TMED","TRUH","FXH","PPH","BBH","BME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665936888","title":"复宏汉霖朱俊：未来所有制药企业都是AI制药企业，不存在不依赖AI的生物制药企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2665936888","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665936888?lang=zh_cn&edition=full","pubTime":"2026-09-05 14:04","pubTimestamp":1788588240,"startTime":"0","endTime":"0","summary":"朱俊坦言，尽管近年来国家批准的创新药数量已领先全球，但临床疗效的提升依然艰难。他强调，如果AI不能进一步赋能，生物医药产业将继续处于原始状态。未来，所有的制药企业都必须是AI制药企业，不存在不依赖AI的生物制药企业。朱俊总认为，在全球变局下，只要企业能够用好AI、抓住精准人群并解决真实的临床痛点，即使十个机会中只能抓住一个，也足以支撑企业的长远发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2026-09-05/doc-iniquccs3668085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HK0000320223.HKD","CHAT","BK1574","BK1161","AIPO","HK0000320264.USD","MRNX","MRNY","03069","BK1191","IBBQ","VTHR","HK0000306701.USD","HK0000165453.HKD","BBP","HK0000306685.HKD","ARTY","QTOC","02696","01477","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664337721","title":"康宁杰瑞生物制药回购56,000股 耗资492,430港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664337721","media":"财闻","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664337721?lang=zh_cn&edition=full","pubTime":"2026-09-04 20:53","pubTimestamp":1788526380,"startTime":"0","endTime":"0","summary":"9月4日，康宁杰瑞生物制药于2026年9月4日在香港联交所回购56,000股普通股，每股回购价格最高HKD8.8、最低HKD8.75，付出价格总额HKD492,430。回购股份拟持作库存股份，拟注销数目为0。回购后，已发行股份数目由968,056,697股减至968,000,697股，库存股份数目由6,325,000股增至6,381,000股，已发行股份总数维持974,381,697股。此次回购依据2026年6月12日获通过的回购授权进行，该授权可回购股份总数为96,850,669股。回购后暂止期截至2026年10月4日。呈交者为执行董事徐霆。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-04/doc-iniqsrak4001786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["EWH","03069","BBP","MRNY","MRNX","IBBQ","CNAV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664521258","title":"美股异动丨诺华制药涨超7%，多发性硬化症口服药后期临床试验结果积极","url":"https://stock-news.laohu8.com/highlight/detail?id=2664521258","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664521258?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:18","pubTimestamp":1788272338,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BBH","RXL","MEDX","XPH","IE0002141913.USD","LU2322448957.HKD","NVS","LU0211331839.USD","SBIO","HELX","MEDI","IE00BJJMRZ35.SGD","PBPH","IEIH","FTXH","IBB","BIOY","IE0009355771.USD","BBP","MRNY","BIB","PJP","IEHS","TMED","BME","PPH","CANC","MRNX","IE00BFTCPJ56.SGD","LU2473716301.USD","LFSC","SYNB","FBT","AZNH","BK4588","PBE","IDNA","BK4585","GNOM","LU0070302665.USD","LU2272731600.USD","PSCH","RSPH","WDNA","XBIX","IE00B4R5TH58.HKD","IBRN","IYH","IE00BJT1NW94.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663282078","title":"药闻 | 英硅智能上市后首份半年报扭亏 创新药研发加速拥抱AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2663282078","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663282078?lang=zh_cn&edition=full","pubTime":"2026-08-31 15:35","pubTimestamp":1788161758,"startTime":"0","endTime":"0","summary":"新华财经上海8月31日电（记者杜康）作为AI制药领域代表性企业之一，英硅智能（03696.HK）日前发布2026年度中期业绩报告。上半年，公司实现总营收1.063亿美元，同比增长287.2%；净利润3554万美元，经调整净利润5123万美元，经营活动现金流转正。这是英硅智能上市后发布的首份半年报，公司也由此前的亏损转为盈利。从收入结构看，药物研发与管线开发仍是主要来源。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313860072952.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313860072952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SBIO","BK4588","IPOS","VTHR","AIPO","BIOY","GDOC","WRND","CHAT","GSKH","BK4585","LFSC","APXH","BBP","PBE","QTOC","IBB","ARTY","AGIX","XLVI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":0.0016},{"period":"3month","weight":0.0619},{"period":"6month","weight":0.1867},{"period":"1year","weight":0.4637},{"period":"ytd","weight":0.2968}],"compareEarnings":[{"period":"1week","weight":0.0042},{"period":"1month","weight":0.0181},{"period":"3month","weight":0.0349},{"period":"6month","weight":0.1117},{"period":"1year","weight":0.1915},{"period":"ytd","weight":0.141}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.013251},{"month":2,"riseRate":0.416667,"avgChangeRate":0.009089},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.010237},{"month":4,"riseRate":0.583333,"avgChangeRate":0.00248},{"month":5,"riseRate":0.583333,"avgChangeRate":0.009273},{"month":6,"riseRate":0.916667,"avgChangeRate":0.050034},{"month":7,"riseRate":0.666667,"avgChangeRate":0.017627},{"month":8,"riseRate":0.666667,"avgChangeRate":0.026611},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.014886},{"month":10,"riseRate":0.583333,"avgChangeRate":-0.014501},{"month":11,"riseRate":0.909091,"avgChangeRate":0.065286},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.005253}],"exchange":"ARCA","name":"Virtus LifeSci Biotech Products ETF","nameEN":"Virtus LifeSci Biotech Products ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Virtus LifeSci Biotech Products ETF(BBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Virtus LifeSci Biotech Products ETF(BBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Virtus LifeSci Biotech Products ETF,BBP,Virtus LifeSci Biotech Products ETF股票,Virtus LifeSci Biotech Products ETF股票老虎,Virtus LifeSci Biotech Products ETF股票老虎国际,Virtus LifeSci Biotech Products ETF行情,Virtus LifeSci Biotech Products ETF股票行情,Virtus LifeSci Biotech Products ETF股价,Virtus LifeSci Biotech Products ETF股市,Virtus LifeSci Biotech Products ETF股票价格,Virtus LifeSci Biotech Products ETF股票交易,Virtus LifeSci Biotech Products ETF股票购买,Virtus LifeSci Biotech Products ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Virtus LifeSci Biotech Products ETF(BBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Virtus LifeSci Biotech Products ETF(BBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}